-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/smoking-pregnancy-infants_disposition-comments.pdf
February 25, 2014 - Windsor, et al,
2000, pp 29-35 (851/p 169) provides a detailed description,
with examples, of how to … A detailed description of the SCRIPT Trial III process
evaluation is presented on pp 415-416: #96, Health … section begins with an
introduction, the goes through the results of the literature
searches and the description … More detailed description of
specific interventions in individual studies would make
the report unwieldy … builds on the AHRQ, 2000 and 2008 for two high-
risk populations, It is essential to present a brief description
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_research-protocol.pdf
April 01, 2013 - Tumor (T) stages
Stage Description
T1 The tumor cannot be felt or seen using imaging techniques
T1a … Lymph node (N) stages
Stage Description
NX Nearby lymph nodes were not assessed
N0 The cancer has … Metastasis (M) stages
Stage Description
M0 The cancer has not spread past nearby lymph nodes
M1 The … Treatment options for clinically localized prostate cancer
Treatment Option Treatment Description
Radical … http://effectivehealthcare.ahrq.gov
Posted Online: March 29, 2013 Page 5
Treatment Option Treatment Description
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-emergency_disposition-comments.pdf
November 27, 2012 - In the description of included studies section,
we added a statement that “in 43 (61%)
studies, migraine … In the description of included studies section,
we added a statement that “in 43 (61%)
studies, migraine … We added a statement in the description of
included studies section that stated, “in 44
studies, migraine … In the description of included studies section,
we added a statement that “in 43 (61%)
studies, migraine … We have added the following information in the
ES and main report (description of included
studies)
-
effectivehealthcare.ahrq.gov/sites/default/files/han.pdf
December 26, 2012 - Han
Slide 1: Conceptual, methodological, and ethical problems
in communicating
uncertainty
in clinical
evidence
Paul Han, MD, MA, MPH
Center for Outcomes Research and Evaluation
Maine Medical
Center
Slide 2: Communicating
uncertainty in clinical …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-survivor-care-transition_disposition-comments.pdf
March 18, 2014 - As is expected in a Technical Brief, it
provides a description of the current state of the
science … This section may benefit from a brief
description of the landscape of late effects. … Otherwise, the
definition of cancer survivorship was clear and
relevant, as was the description of … Peer Reviewer 6 Findings This was an excellent description of existing
models, though there are, from … It would benefit from a brief description of
how guidelines are defined (e.g., consensus of
experts
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-236-maternal-fetal-child-outcomes-disposition-comments.pdf
April 15, 2021 - Commentator
& Affiliation
Section Comment Response
American
Psychiatric
Association
Results Description … This statement seems inconsistent with the
mixed description of the data earlier in the document. … This section provides a nice
description of the challenges of analyzing this literature. … The initial
description notes that the searches were conducted
from inception to December 11, 2018. … The flow diagram refers to articles that were
identified through text mining, yet the description of
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/meditation_research-protocol.pdf
October 17, 2012 - 2) mean hours of total meditation (training + home) 3) hours/duration of recommended
practice 4) description … of participant compliance if any 5) description of participant proficiency in
practicing the meditation … technique 6) description of instructor qualifications. … Attrition Bias:
• Was there a description of withdrawals and dropouts? … These studies adhered to a clear description of the population, setting, approaches, and
http://www.effectivehealthcare.ahrq.gov
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-protocol.pdf
February 01, 2023 - study
design, purpose); clinical characteristics of the sample (e.g., age, race, setting, country);
description … of potential confounding factors and how the study accounted for those confounders;
description of … Description of the strength of evidence grades
Strength of
Evidence Description
High We are very
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/study-design-classification_research.pdf
December 01, 2010 - Description of study design classification tools rejected for further evaluation................8
Table … backtracked in order to classify the studies according to what they felt was the most appropriate
description … Description of study design classification tools rejected for further evaluation
Tool Reference or … M
Examples of this design include:
• A study that presents a description of a single patient or participant … Non-comparative study
Examples of this design include:
• A study that presents a description of a
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy_disposition-comments.pdf
March 11, 2010 - Methods Your description of negative predictive value as applying to specific
populations of women is … The description of how the strength of evidence
was graded was accidently omitted from the draft
report … Methods A description on strength of evidence should be added. … Results p.39 add more description of the methods used in these three
studies.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_slides-2011.pdf
January 01, 2011 - Based on these objectives,
meeting conveners should create a description of the type of patient perspective … Based on this exercise, the researcher can
develop a specific description of the experience needed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/women-hiv_disposition-comments.pdf
November 21, 2016 - However, whether they are the only
group that fits that description (e.g., other groups that
face similar … But the description occurs within a
section on the general availability of resources, and
the Miriam … clarified that we include the Miriam
program as an example of a good or “model”
program:
We provide a description … Peer Reviewer #2 Findings The description of the resources available at the
Immunology Clinic at Miriam … Public Reviewer #2
(Laura Cheever)
Findings For completeness, such a description should be
included
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/wheelchair-service_disposition-comments.pdf
January 01, 2012 - inadequate specification of the
targeted population to whom the report is directed or very
incomplete description … Because we are merely presenting a description of what
evidence is available on service delivery, it … We clarified the source of the prescription process
description. … Description and Context of Wheeled Mobility Service
Delivery- The first sentence oversimplifies and … This does not coincide with the description of the search on
page 4.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-blood-transfusion-protocol-amendment.pdf
February 04, 2025 - Finally, a final version of the narrative summary and description of the
diagram(s) will be prepared
-
effectivehealthcare.ahrq.gov/sites/default/files/assessing-quality.ppt
January 01, 2010 - Transparency of process
Full reporting of all elements of quality for each individual study
Explicit description … examples) of how each criterion was operationalized
Clear reporting of how team members scored quality
Description
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_clinician.pdf
May 01, 2011 - .
�� A description of the options that
are available for patients with a
broken hip.
�� The evidence
-
effectivehealthcare.ahrq.gov/sites/default/files/johnson_-ahrq-mcda-presentation.pdf
August 27, 2012 - responses
– Stated preference/revealed preference experiments
Cognitive challenges
– Effective description
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0775-150722.pdf
May 12, 2015 - Topic Description
Nominator(s): Health care professional association
Nomination According to the
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
March 10, 2010 - in the
population description with ?muscle-related side effects.? … If this description is insufficient, we request that the EPC explain what
additional information is … (Ref 116)
Gaudiani was penalized for lack of an ITT analysis, despite the
description in the publication … If this description is
insufficient, the study protocol (on file with the FDA) states "For the
efficacy … Here is a description of the ITT analysis, taken from the
Clinical Study Report, on file with the FDA
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
March 15, 2016 - We added to the SoE
description the factors we used in judging
the SoE as moderate. … But we can't follow the
reviewer's description of the clinical effects
of this. … We have moved the description of studies
that assess nutritional risk factors for gout
or high serum … TEP Reviewer #3 Introduction Background: • ES-1, line 55: the description of joints involved should … Figure A on Page ES-5 starts a description (Low Purine,
Alcohol, hydration, but drops off with “etc”